184 related articles for article (PubMed ID: 37219677)
21. Centromere protein N promotes lung adenocarcinoma progression by activating PI3K/AKT signaling pathway.
Zheng Y; You H; Duan J; Chen B; Wu C; Chen P; Wang M
Genes Genomics; 2022 Sep; 44(9):1039-1049. PubMed ID: 35150399
[TBL] [Abstract][Full Text] [Related]
22. ADAM12 promotes the resistance of lung adenocarcinoma cells to EGFR-TKI and regulates the immune microenvironment by activating PI3K/Akt/mTOR and RAS signaling pathways.
Li K; Quan L; Huang F; Li Y; Shen Z
Int Immunopharmacol; 2023 Sep; 122():110580. PubMed ID: 37418984
[TBL] [Abstract][Full Text] [Related]
23. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
[TBL] [Abstract][Full Text] [Related]
24. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1.
Xu T; Yin F; Shi K
Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329
[TBL] [Abstract][Full Text] [Related]
25. SMC2 knockdown inhibits malignant progression of lung adenocarcinoma by upregulating BTG2 expression.
He Y; Wang Y; Luo Z; Zhang X; Bai H; Wang J
Cell Signal; 2024 Aug; 120():111216. PubMed ID: 38729325
[TBL] [Abstract][Full Text] [Related]
26. PDGFBB facilitates tumorigenesis and malignancy of lung adenocarcinoma associated with PI3K-AKT/MAPK signaling.
Xiu-Ying H; Yue-Xiang Z; Hui-Si Y; Hong-Zhou Y; Qing-Jie X; Ting-Hua W
Sci Rep; 2024 Feb; 14(1):4191. PubMed ID: 38378786
[TBL] [Abstract][Full Text] [Related]
27. NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m
Du X; Cheng C; Yang Y; Fan B; Wang P; Xia H; Ni X; Liu Q; Lu L; Wei L
Mol Carcinog; 2024 May; 63(5):962-976. PubMed ID: 38411298
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of CCT3 predicts poor prognosis and promotes cell proliferation via inhibition of ferroptosis and activation of AKT signaling in lung adenocarcinoma.
Wang K; He J; Tu C; Xu H; Zhang X; Lv Y; Song C
BMC Mol Cell Biol; 2022 Jun; 23(1):25. PubMed ID: 35773623
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
[TBL] [Abstract][Full Text] [Related]
31. EIF4A3 Acts on the PI3K-AKT-ERK1/2-P70S6K Pathway through FLOT1 to Influence the Development of Lung Adenocarcinoma.
Yu W; Liang J; Fang T; Jiang J; Zhao R; Li R; Han J; Tian H
Mol Cancer Res; 2023 Jul; 21(7):713-725. PubMed ID: 37011005
[TBL] [Abstract][Full Text] [Related]
32. CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma.
Chen J; Alduais Y; Zhang K; Zhu X; Chen B
J Cell Mol Med; 2021 Oct; 25(19):9199-9213. PubMed ID: 34431227
[TBL] [Abstract][Full Text] [Related]
33. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma.
Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L
Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507
[No Abstract] [Full Text] [Related]
34. Rab22a promotes the proliferation, migration, and invasion of lung adenocarcinoma via up-regulating PI3K/Akt/mTOR signaling pathway.
Wang J; Luo X; Lu J; Wang X; Miao Y; Li Q; Wang L
Exp Cell Res; 2022 Jul; 416(2):113179. PubMed ID: 35487271
[TBL] [Abstract][Full Text] [Related]
35. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis.
Zhang M; Liang Y; Song P
J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
37. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
Chen Y; Wu L; Bao M
Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
[TBL] [Abstract][Full Text] [Related]
38. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
Chen Y; Tang J; Lu T; Liu F
Thorac Cancer; 2020 Jul; 11(7):1848-1860. PubMed ID: 32395869
[TBL] [Abstract][Full Text] [Related]
39. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
40. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma.
Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X
PeerJ; 2022; 10():e14206. PubMed ID: 36275477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
